The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nonalcoholic Steatohepatitis (NASH) Market Research Report 2024
Synopsis
Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.
The global Nonalcoholic Steatohepatitis (NASH) market was valued at US$ 3064.2 million in 2023 and is anticipated to reach US$ 46230 million by 2030, witnessing a CAGR of 46.7% during the forecast period 2024-2030.
Non-alcoholic drinks, also known as mocktails or alcohol-free beverages, are beverages that do not contain any alcohol. These drinks are a popular choice for those who do not consume alcohol, including designated drivers, people who are underage, or individuals who wish to avoid alcohol for personal or health reasons. There are a wide variety of non-alcoholic drinks available, ranging from soft drinks to fresh juices, herbal infusions, and specialty mocktails. Some examples of non-alcoholic drinks include: 1. Soft Drinks: This category includes popular carbonated beverages like cola, lemon-lime sodas, ginger ale, and root beer. These drinks are often sweet and fizzy, providing a refreshing and enjoyable beverage option. 2. Fruit Juices: Freshly squeezed or packaged fruit juices, such as orange, apple, grapefruit, pineapple, or cranberry juice, are a common choice. These juices offer a natural and flavorful alternative to alcoholic beverages. 3. Smoothies: Made from a blend of fruits, vegetables, yogurt, and other ingredients, smoothies provide a nutritious and wholesome non-alcoholic option. They can be customized with various flavors and ingredients to suit individual preferences. 4. Herbal Infusions and Tea: Herbal teas and infusions, such as chamomile, peppermint, green tea, or hibiscus tea, are popular choices. These beverages are caffeine-free and often have relaxing or soothing properties. 5. Mocktails: These are non-alcoholic cocktails that mimic the flavors and presentation of traditional cocktails. They are typically made with a combination of juices, sodas, and garnishes, providing a fancy and enjoyable experience without the alcohol. 6. Sparkling Water: Carbonated water or mineral water with added flavors or fruit infusions is a refreshing and hydrating option. It is often consumed plain or mixed with juices or syrups. These non-alcoholic drinks offer a variety of flavors, textures, and options for those who prefer not to consume alcohol. They are a great way to enjoy a beverage while socializing or relaxing without the effects of alcohol.
This report aims to provide a comprehensive presentation of the global market for Nonalcoholic Steatohepatitis (NASH), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonalcoholic Steatohepatitis (NASH).
Report Scope
The Nonalcoholic Steatohepatitis (NASH) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nonalcoholic Steatohepatitis (NASH) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nonalcoholic Steatohepatitis (NASH) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Segment by Type
Obeticholic acid（OCA）
Selonsertib
Segment by Application
Hospital Pharmacy
Online Provider
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nonalcoholic Steatohepatitis (NASH) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.
The global Nonalcoholic Steatohepatitis (NASH) market was valued at US$ 3064.2 million in 2023 and is anticipated to reach US$ 46230 million by 2030, witnessing a CAGR of 46.7% during the forecast period 2024-2030.
Non-alcoholic drinks, also known as mocktails or alcohol-free beverages, are beverages that do not contain any alcohol. These drinks are a popular choice for those who do not consume alcohol, including designated drivers, people who are underage, or individuals who wish to avoid alcohol for personal or health reasons. There are a wide variety of non-alcoholic drinks available, ranging from soft drinks to fresh juices, herbal infusions, and specialty mocktails. Some examples of non-alcoholic drinks include: 1. Soft Drinks: This category includes popular carbonated beverages like cola, lemon-lime sodas, ginger ale, and root beer. These drinks are often sweet and fizzy, providing a refreshing and enjoyable beverage option. 2. Fruit Juices: Freshly squeezed or packaged fruit juices, such as orange, apple, grapefruit, pineapple, or cranberry juice, are a common choice. These juices offer a natural and flavorful alternative to alcoholic beverages. 3. Smoothies: Made from a blend of fruits, vegetables, yogurt, and other ingredients, smoothies provide a nutritious and wholesome non-alcoholic option. They can be customized with various flavors and ingredients to suit individual preferences. 4. Herbal Infusions and Tea: Herbal teas and infusions, such as chamomile, peppermint, green tea, or hibiscus tea, are popular choices. These beverages are caffeine-free and often have relaxing or soothing properties. 5. Mocktails: These are non-alcoholic cocktails that mimic the flavors and presentation of traditional cocktails. They are typically made with a combination of juices, sodas, and garnishes, providing a fancy and enjoyable experience without the alcohol. 6. Sparkling Water: Carbonated water or mineral water with added flavors or fruit infusions is a refreshing and hydrating option. It is often consumed plain or mixed with juices or syrups. These non-alcoholic drinks offer a variety of flavors, textures, and options for those who prefer not to consume alcohol. They are a great way to enjoy a beverage while socializing or relaxing without the effects of alcohol.
This report aims to provide a comprehensive presentation of the global market for Nonalcoholic Steatohepatitis (NASH), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonalcoholic Steatohepatitis (NASH).
Report Scope
The Nonalcoholic Steatohepatitis (NASH) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nonalcoholic Steatohepatitis (NASH) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nonalcoholic Steatohepatitis (NASH) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Segment by Type
Obeticholic acid（OCA）
Selonsertib
Segment by Application
Hospital Pharmacy
Online Provider
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nonalcoholic Steatohepatitis (NASH) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Obeticholic acid（OCA）
1.2.3 Selonsertib
1.3 Market by Application
1.3.1 Global Nonalcoholic Steatohepatitis (NASH) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Online Provider
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Perspective (2019-2030)
2.2 Nonalcoholic Steatohepatitis (NASH) Growth Trends by Region
2.2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nonalcoholic Steatohepatitis (NASH) Historic Market Size by Region (2019-2024)
2.2.3 Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Region (2025-2030)
2.3 Nonalcoholic Steatohepatitis (NASH) Market Dynamics
2.3.1 Nonalcoholic Steatohepatitis (NASH) Industry Trends
2.3.2 Nonalcoholic Steatohepatitis (NASH) Market Drivers
2.3.3 Nonalcoholic Steatohepatitis (NASH) Market Challenges
2.3.4 Nonalcoholic Steatohepatitis (NASH) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nonalcoholic Steatohepatitis (NASH) Players by Revenue
3.1.1 Global Top Nonalcoholic Steatohepatitis (NASH) Players by Revenue (2019-2024)
3.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Players (2019-2024)
3.2 Global Nonalcoholic Steatohepatitis (NASH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nonalcoholic Steatohepatitis (NASH) Revenue
3.4 Global Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio
3.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nonalcoholic Steatohepatitis (NASH) Revenue in 2023
3.5 Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Area Served
3.6 Key Players Nonalcoholic Steatohepatitis (NASH) Product Solution and Service
3.7 Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nonalcoholic Steatohepatitis (NASH) Breakdown Data by Type
4.1 Global Nonalcoholic Steatohepatitis (NASH) Historic Market Size by Type (2019-2024)
4.2 Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Type (2025-2030)
5 Nonalcoholic Steatohepatitis (NASH) Breakdown Data by Application
5.1 Global Nonalcoholic Steatohepatitis (NASH) Historic Market Size by Application (2019-2024)
5.2 Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nonalcoholic Steatohepatitis (NASH) Market Size (2019-2030)
6.2 North America Nonalcoholic Steatohepatitis (NASH) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2019-2024)
6.4 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size (2019-2030)
7.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2019-2024)
7.4 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size (2019-2030)
8.2 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2019-2024)
8.4 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size (2019-2030)
9.2 Latin America Nonalcoholic Steatohepatitis (NASH) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2019-2024)
9.4 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size (2019-2030)
10.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2019-2024)
10.4 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Introduction
11.1.4 AstraZeneca Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 Arena Pharmaceuticals
11.2.1 Arena Pharmaceuticals Company Detail
11.2.2 Arena Pharmaceuticals Business Overview
11.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.2.4 Arena Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.2.5 Arena Pharmaceuticals Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Nonalcoholic Steatohepatitis (NASH) Introduction
11.3.4 GSK Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.3.5 GSK Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Detail
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Introduction
11.4.4 Novo Nordisk Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.4.5 Novo Nordisk Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Nonalcoholic Steatohepatitis (NASH) Introduction
11.5.4 Roche Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Vivus
11.6.1 Vivus Company Detail
11.6.2 Vivus Business Overview
11.6.3 Vivus Nonalcoholic Steatohepatitis (NASH) Introduction
11.6.4 Vivus Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.6.5 Vivus Recent Development
11.7 Arisaph Pharmaceuticals
11.7.1 Arisaph Pharmaceuticals Company Detail
11.7.2 Arisaph Pharmaceuticals Business Overview
11.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.7.4 Arisaph Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.7.5 Arisaph Pharmaceuticals Recent Development
11.8 Cempra Pharmaceuticals
11.8.1 Cempra Pharmaceuticals Company Detail
11.8.2 Cempra Pharmaceuticals Business Overview
11.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.8.4 Cempra Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.8.5 Cempra Pharmaceuticals Recent Development
11.9 Galectin Therapeutics
11.9.1 Galectin Therapeutics Company Detail
11.9.2 Galectin Therapeutics Business Overview
11.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Introduction
11.9.4 Galectin Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.9.5 Galectin Therapeutics Recent Development
11.10 Galmed Pharmaceuticals
11.10.1 Galmed Pharmaceuticals Company Detail
11.10.2 Galmed Pharmaceuticals Business Overview
11.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.10.4 Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.10.5 Galmed Pharmaceuticals Recent Development
11.11 Genfit
11.11.1 Genfit Company Detail
11.11.2 Genfit Business Overview
11.11.3 Genfit Nonalcoholic Steatohepatitis (NASH) Introduction
11.11.4 Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.11.5 Genfit Recent Development
11.12 Gilead
11.12.1 Gilead Company Detail
11.12.2 Gilead Business Overview
11.12.3 Gilead Nonalcoholic Steatohepatitis (NASH) Introduction
11.12.4 Gilead Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2019-2024)
11.12.5 Gilead Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
